8-K: UHS sets 2026 exec bonuses, lifts PBRSU cap

Universal Health Services set 2026 executive bonus targets, awarded new RSUs/PBRSUs at $185.09, and raised PBRSU maximum payout to 200% using a new three-year average performance method.

Summary

• On March 26, 2026, the Compensation Committee approved 2026 annual incentive bonus formulae under the 2022 Executive Incentive Plan, with payouts ranging from 0% to 200% of target based on performance.
• Target bonus as a percentage of base salary for 2026: Marc D. Miller (CEO) 150%; Steve G. Filton (CFO) 100%; Edward H. Sim (EVP, Acute Care) 100%; Matthew J. Peterson (EVP, Behavioral Health) 100%.
• For CEO Marc D. Miller and CFO Steve G. Filton, 100% of the annual bonus is tied to corporate performance; for Edward H. Sim and Matthew J. Peterson, 25% is tied to corporate performance and 75% to divisional income targets.
• Corporate performance metrics comprise adjusted net income per diluted share attributable to UHS and return on capital (adjusted net income attributable to UHS divided by quarterly average net capital) for FY2026.
• Divisional income targets for Sim and Peterson are based on projected aggregate pre-tax income for the acute care and behavioral health segments, net of a charge for estimated cost of capital, with potential adjustments for nonrecurring/non-operational items.
• A discretionary cash bonus of $1.07 million for the year ended December 31, 2025 was approved for Executive Chairman Alan B. Miller on March 26, 2026.
• On March 26, 2026, the Committee granted time-based RSUs and performance-based RSUs (PBRSUs) under the 2020 Omnibus Stock and Incentive Plan, calculated using the $185.09 closing price of Class B shares.
• RSUs vest in four equal installments on the first, second, third, and fourth anniversaries of the March 26, 2026 grant date.
• PBRSU performance will be measured on the average of the three-year period 2026–2028 (versus prior single end-period assessment), with a 50% payout at the 90% threshold of three-year average Adjusted EBITDA net of NCI and a maximum 200% payout at 110% or greater (up from 150%).
• Award counts at target: Marc D. Miller 29,715 RSUs and 29,715 PBRSUs; Alan B. Miller 14,153 and 14,153; Steve G. Filton 6,850 and 6,850; Edward G. Sim 6,404 and 6,404; Matthew J. Peterson 5,627 and 5,627.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a modest positive governance update that strengthens pay-for-performance alignment and peer conformity without providing or altering financial performance guidance.

Positives

• Clear pay-for-performance framework with objective corporate metrics (adjusted EPS and return on capital) and divisional income goals.
• Alignment with peer practices by moving PBRSU performance to a three-year average and increasing the maximum payout to 200%.
• Multi-year equity awards (RSUs/PBRSUs) promote executive retention, with four-year vesting for RSUs and a three-year PBRSU measurement period.
• Transparency on award sizing using the $185.09 share price and disclosure of exact RSU/PBRSU grant counts.

Negatives

• Raising the PBRSU maximum payout to 200% could increase compensation expense if targets are exceeded.
• Heavy reliance on adjusted metrics (e.g., exclusion of certain nonrecurring/non-operational items) may reduce comparability to GAAP results.
• A $1.07 million discretionary cash bonus to the Executive Chairman for 2025 may draw governance scrutiny due to its discretionary nature.
• Equity grants introduce potential shareholder dilution over the vesting/earn-out periods.

Future Outlook

Compensation outcomes for 2026 will depend on achieving specified adjusted EPS, return on capital, and divisional income targets; PBRSU vesting will hinge on average Adjusted EBITDA net of NCI over 2026–2028, with payouts from 0% to 200% of target.

Management Comments

• The Committee determined that, beginning with March 26, 2026 grants, PBRSU performance will be measured on a three-year average (2026–2028) rather than solely on aggregate performance at the end of the third year.
• To more closely align with peer practices, the maximum PBRSU payout increases to 200% of target (from 150%), while the 50% payout at the 90% minimum threshold remains unchanged.

Industry Context

StockSavvy.ai notes that large U.S. hospital and behavioral health peers increasingly emphasize multi-year performance equity with 0%–200% payout ranges and adjusted operating metrics. UHS’s shift to a three-year average and a 200% PBRSU cap aligns with practices observed at providers such as HCA Healthcare, Tenet Healthcare, and Acadia Healthcare, focusing incentives on sustained profitability and capital efficiency.

Comparison to Industry Standards

• UHS’s 0%–200% PBRSU payout scale is consistent with common LTI designs across S&P 500 healthcare services companies, including HCA Healthcare (HCA) and Tenet Healthcare (THC), where maximum payout often caps at 200% for outperformance.
• Use of multi-year performance (three-year average) and adjusted operating metrics (Adjusted EBITDA, adjusted EPS, return on capital) aligns with sector peers such as Acadia Healthcare (ACHC), which typically weight LTI to multi-year, operating-metric-based PBRSUs.
• CEO and CFO target bonus opportunities of 150% and 100% of base salary, respectively, are in line with large-cap healthcare providers’ cash incentive targets, which commonly range from 100% to 175% for CEOs and around 75%–125% for CFOs.

Corporate Governance

Related Party Transactions

• A discretionary cash bonus of $1.07 million for 2025 was approved on March 26, 2026 for Executive Chairman Alan B. Miller.

Stakeholder Impact

• Shareholders: Potential dilution from RSU/PBRSU issuance over the vesting and performance periods.
• Executives: Higher upside (200% PBRSU cap) and clearer alignment with multi-year performance may enhance retention and motivation.
• Employees: No direct changes disclosed to broad-based compensation; governance clarity may support organizational performance culture.
• Creditors: No immediate balance sheet impact; long-term equity awards do not affect near-term liquidity.
• Board/Compensation Committee: Enhanced alignment with peer standards may mitigate pay-practice scrutiny.

Next Steps

• Assess FY2026 performance against adjusted EPS and return on capital targets for corporate bonus determination.
• Evaluate acute care and behavioral health divisional pre-tax income (net of cost-of-capital charge) for Sim and Peterson’s divisional bonus components.
• Monitor PBRSU performance over the three-year period ending December 31, 2028 to determine final payouts (0%–200%).
• RSUs to vest in four equal tranches on the first through fourth anniversaries of March 26, 2026.
• Process and pay the $1.07 million discretionary cash bonus to the Executive Chairman for 2025.

Key Dates

Recommendation

The update refines incentive structures and aligns with peer practices but does not alter fundamentals or provide performance guidance; maintain a neutral stance pending operating results.

Keywords

Universal Health Services, UHS, executive compensation, incentive plan, RSU, PBRSU, Adjusted EBITDA, adjusted EPS, return on capital, behavioral health, acute care, 2020 Omnibus Stock and Incentive Plan, 2022 Executive Incentive Plan, Alan B. Miller, Marc D. Miller, Steve G. Filton